Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Diabetes

• Publication date

  2015-10-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db15-0973PMID 26470787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gut-brain mechanisms controlling glucose homeostasis

  2015cited by this paper
• Vagal mediation of GLP-1's effects on food intake and glycemia.

  2015cited by this paper
• Vagal Sensory Neuron Subtypes that Differentially Control Breathing.

  2015cited by this paper
• Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.

  2015cited by this paper
• Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes

  2015cited by this paper
• Gut Vagal Afferents Differentially Modulate Innate Anxiety and Learned Fear

  2014cited by this paper
• PPARγ in vagal neurons regulates high-fat diet induced thermogenesis.

  2014cited by this paper
• The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

  2014cited by this paper
• Ability of GLP-1 to decrease food intake is dependent on nutritional status.

  2014cited by this paper
• A method of nodose ganglia injection in Sprague-Dawley rat.

  2014cited by this paper
• Circadian Secretion of the Intestinal Hormone GLP-1 by the Rodent L Cell

  2014cited by this paper
• Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.

  2014cited by this paper
• Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity

  2014cited by this paper
• Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats

  2013cited by this paper
• Cooperation between brain and islet in glucose homeostasis and diabetes

  2013cited by this paper
• Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways.

  2013cited by this paper
• Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

  2013cited by this paper
• Intraperitoneal (IP) glucagon-like peptide-1 (GLP-1) injections and meals in rats increase intestinal lymphatic GLP-1 similarly

  2012cited by this paper
• Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

  2012cited by this paper
• Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms.

  2012cited by this paper
• Vagal Afferents Mediate Early Satiation and Prevent Flavour Avoidance Learning in Response to Intraperitoneally Infused Exendin‐4

  2012cited by this paper
• Intraportal administration of DPP‐IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats

  2012cited by this paper
• Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice.

  2011influential reference
• Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

  2011cited by this paper
• The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.

  2011cited by this paper
• Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.

  2009cited by this paper
• Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

  2009cited by this paper
• Central and Peripheral Regulation of Food Intake and Physical Activity: Pathways and Genes

  2008cited by this paper
• Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.

  2007cited by this paper
• Nociceptor‐specific gene deletion using heterozygous NaV1.8‐Cre recombinase mice

  2005cited by this paper
• The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.

  2005cited by this paper
• Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells.

  2004cited by this paper
• Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice.

  2004cited by this paper
• Neither Agouti-Related Protein nor Neuropeptide Y Is Critically Required for the Regulation of Energy Homeostasis in Mice

  2002cited by this paper
• Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms.

  2000cited by this paper
• Functional and chemical anatomy of the afferent vagal system.

  2000influential reference
• Effects of GLP-1 on Gastric Emptying, Antropyloric Motility, and Transpyloric Flow in Response to a Nonnutrient Liquid

  1998cited by this paper
• Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.

  1997cited by this paper
• Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.

  1997cited by this paper
• Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y

  1996cited by this paper
• Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.

  1996cited by this paper
• Hepatic portal insulin antibody infusion increases, but insulin does not alter, spontaneous meal size in rats.

  1995cited by this paper
• A method for selective section of vagal afferent or efferent axons in the rat.

  1994cited by this paper
• GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans

  1989cited by this paper

• Gut-derived GLP-1 released by rare sugar D-allulose cooperates with insulin to activate left-sided vagal afferents and enhance insulin sensitivity

  2026cites this paper
• GLP-1 physiology and pharmacology along the gut-brain axis

  2026influential citation
• Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development

  2026cites this paper
• The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

  2026cites this paper
• Incretin-Based Therapies: A Novel Pathway in Addiction Treatment.

  2026cites this paper
• Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response

  2025cites this paper
• Vagal oxytocin receptors are necessary for esophageal motility and function

  2025cites this paper
• The Effects of GLP-1 Agonists on Musculoskeletal Health and Orthopedic Care

  2025cites this paper
• Gut Hormones and Inflammatory Bowel Disease

  2025cites this paper
• Abilities of Rare Sugar Members to Release Glucagon-like Peptide-1 and Suppress Food Intake in Mice

  2025cites this paper
• GLP-1 and the Neurobiology of Eating Control: Recent Advances

  2025cites this paper
• Gut sensing of food ingredients and interoception‐mediated regulation of feeding and glucose metabolism

  2025cites this paper
• When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies.

  2025cites this paper
• Incretin Receptors in the Peripheral Nervous System: Implications for Obesity Treatment and Peripheral Neuropathy.

  2025cites this paper
• The Enteric Neuronal Circuitry: A Key Ignored Player in Nutrient Sensing Along the Gut–Brain Axis

  2025cites this paper
• The role of the gut-brain axis in diseases.

  2025cites this paper
• A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK)

  2025cites this paper
• GLP-1 and ghrelin inversely regulate insulin secretion and action in pancreatic islets, vagal afferents and hypothalamus for controlling glycemia and feeding.

  2025cites this paper
• Expandable konjac fiber modulates appetite and chyme digestion in vivo by stomach-intestine-brain axis.

  2025cites this paper
• Vagal Sensory Gut–Brain Pathways That Control Eating—Satiety and Beyond

  2025cites this paper
• Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice

  2025cites this paper
• The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP

  2025cites this paper
• AgRP mediated calcium Inhibition of feeding via the vagal afferent nerve-brain pathway

  2025cites this paper
• RYGB Induces Vagal Sensory Neuropathy Characterized by Altered GLP1R Expression and Enhanced Exendin-4 Responsiveness in Male Mice.

  2025cites this paper
• A neural entero-pancreatic pathway that regulates insulin secretion and glucose tolerance

  2025cites this paper
• Diabetic gastrointestinal autonomic neuropathy: Integrating neuronal degeneration and gut microbial dysbiosis

  2025cites this paper
• Mechanistic insights into the liver–brain axis during chronic liver disease

  2025cites this paper
• A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia

  2025cites this paper
• Comparing the anorexigenic effects and mechanisms of gut-derived GLP-1 and its receptor agonists: insights into incretin-based therapies for obesity

  2025cites this paper
• Gut Microbiome Regulation of Gut Hormone Secretion

  2025cites this paper
• Understanding the release mechanisms and secretion patterns for glucagon-like peptide-1 using the isolated perfused intestine as a model

  2025cites this paper
• PACAP Signaling Network in the Nucleus Accumbens Core Regulates Reinstatement Behavior in Rat

  2025cites this paper
• Vagal Oxytocin Receptors as Molecular Targets in Gut–Brain Signaling: Implications for Appetite, Satiety, Obesity, and Esophageal Motility—A Narrative Review

  2025cites this paper
• Brain-Derived GLP-1—Understanding the Physiological Function and Anti-obesity Potential of Preproglucagon Neurons

  2025influential citation
• Effects of physical form of β-lactoglobulin and calcium ingestion on GLP-1 secretion, gastric emptying and energy intake in humans: a randomised crossover trial

  2024cites this paper
• The vagus nerve mediates the physiological but not pharmacological effects of PYY3-36 on food intake

  2024cites this paper
• Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function.

  2024cites this paper
• The role of glucagon‐like peptide 1 receptor agonists for weight control in individuals with acquired hypothalamic obesity—A systematic review

  2024cites this paper
• Transfer with microbiota from lean donors prevents excessive weight gain and restores gut-brain vagal signaling in obese rats maintained on a high fat diet

  2024cites this paper
• The gut–brain axis in appetite, satiety, food intake, and eating behavior: Insights from animal models and human studies

  2024cites this paper
• Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart

  2024cites this paper
• Brain Defense of Glycemia in Health and Diabetes.

  2024cites this paper
• Novel neural pathways targeted by GLP-1R agonists and bariatric surgery

  2024cites this paper
• Ghrelin–LEAP2 interactions along the stomach–liver axis

  2024cites this paper
• Annual Prize Lecture 2024: Endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes

  2024cites this paper
• Advances in the biosynthesis of D-allulose

  2024cites this paper
• Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

  2024cites this paper
• Application and management of continuous glucose monitoring in diabetic kidney disease

  2024cites this paper
• Incretin hormones and obesity

  2024cites this paper
• Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility

  2024cites this paper
• Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges

  2024cites this paper
• A homeostatic gut-to-brain insulin antagonist restrains neuronally stimulated fat loss

  2024cites this paper
• Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide

  2024cites this paper
• Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management.

  2024cites this paper
• Anekomochi glutinous rice provides low postprandial glycemic response by enhanced insulin action via GLP-1 release and vagal afferents activation

  2024cites this paper
• Dissociable hindbrain GLP1R circuits for satiety and aversion

  2024cites this paper
• A sympathetic brake on gut GLP-1 release.

  2024cites this paper
• G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

  2024cites this paper
• A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity

  2024cites this paper
• The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues.

  2024cites this paper
• Novel therapeutic strategy for obesity through the gut microbiota-brain axis: A review article

  2024cites this paper
• Limited evidence for anatomical contacts between intestinal GLP-1 cells and vagal neurons in male mice

  2024cites this paper
• Incretin hormones and pharmacomimetics rapidly inhibit AgRP neuron activity to suppress appetite

  2024cites this paper
• Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats

  2024cites this paper
• Neuroendocrine gut-brain signaling in obesity.

  2024cites this paper
• Small intestinal CaSR-dependent and CaSR-independent protein sensing regulates feeding and glucose tolerance in rats

  2024cites this paper
• Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

  2024cites this paper
• Seeking satiety: From signals to solutions

  2023cites this paper
• Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?

  2023cites this paper
• Recent advances in investigating odor-taste interactions: Psychophysics, neuroscience, and microfluidic techniques

  2023cites this paper
• The protective role of GLP-1 in neuro-ophthalmology

  2023cites this paper
• Gut–vagus–NTS neural pathway in controlling feeding behaviors

  2023cites this paper
• GLP-1 Increases Circulating Leptin Levels in Truncal Vagotomized Rats

  2023cites this paper
• Sex differences in glycolipidic disorders after exposure to maternal hyperglycemia during early development

  2023cites this paper
• Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes

  2023cites this paper
• Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile Acids

  2023cites this paper
• How dietary amino acids and high protein diets influence insulin secretion

  2023cites this paper
• Central GLP-1 Resistance Induced by Severe Traumatic Brain Injury Was Associated with Persistent Hyperglycemia in Humans

  2023cites this paper
• Peripheral administration of neuropeptide W inhibits gastric emptying in rats: the role of small diameter afferent fibers and cholecystokinin receptors.

  2023cites this paper
• Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem

  2023cites this paper
• The importance of estradiol for body weight regulation in women

  2022cites this paper
• Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Neuroinflammation: Implications for Neurodegenerative Disease Treatment.

  2022cites this paper
• How gut hormones shape reward: a systematic review of the role of ghrelin and GLP-1 in human fMRI

  2022cites this paper
• The Elusive Cephalic Phase Insulin Response: Triggers, Mechanisms, and Functions.

  2022cites this paper
• Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis

  2022cites this paper
• Signaling pathways in obesity: mechanisms and therapeutic interventions

  2022cites this paper
• GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein

  2022cites this paper
• Dietary Gamma-Aminobutyric Acid (GABA) Induces Satiation by Enhancing the Postprandial Activation of Vagal Afferent Nerves

  2022cites this paper
• Role of the gut–brain axis in energy and glucose metabolism

  2022cites this paper
• Regulation of body weight: Lessons learned from bariatric surgery

  2022cites this paper
• Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review

  2022cites this paper
• Role of brain-gut-muscle axis in human health and energy homeostasis

  2022cites this paper
• Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA)

  2022cites this paper
• Silencing gut CCK cells alters gut reaction to sugar

  2022cites this paper
• The alpha‐7 nicotinic acetylcholine receptor agonist GTS‐21 engages the glucagon‐like peptide‐1 incretin hormone axis to lower levels of blood glucose in db/db mice

  2022cites this paper
• Physiological and pharmacological actions of glucagon like peptide-1 (GLP-1) in domestic animals

  2022cites this paper
• AN INSIGHT INTO THE TREATMENT STRATEGIES OF OBESITY USING SEMAGLUTIDE AND ITS COMPETITIVE ANALOGUES: A REVIEW ARTICLE

  2022cites this paper
• The Enteroendocrine System in Obesity.

  2022cites this paper
• Regulation of systemic metabolism by the autonomic nervous system consisting of afferent and efferent innervation.

  2021cites this paper
• 食後ホルモンインスリン・GLP-1の求心性迷走神経を介した摂食・糖代謝調節

  2021cites this paper